Life Sciences
Amylyx Pharmaceuticals Puts Canadians Living with ALS First
Reflections on progress and urgency from a ‘made in Canada’ biotech focused on progressive neurodegenerative diseases.  Time is the enemy of people living with amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig’s disease. ALS is a relentlessly progressive neurodegenerative disease caused by motor neuron death in the brain and spinal cord. A diagnosis … Continued